van Oosterhout, M., Levarht, E., Sont, J., Huizinga, T., Toes, R., & van Laar, J. M. (2005). Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNFα and IL18 but not CXCL12.
シカゴスタイル引用形van Oosterhout, M., E. Levarht, J. Sont, T. Huizinga, R. Toes, , J M. van Laar. Clinical Efficacy of Infliximab Plus Methotrexate in DMARD Naive and DMARD Refractory Rheumatoid Arthritis Is Associated With Decreased Synovial Expression of TNFα and IL18 but Not CXCL12. 2005.
MLA引用形式van Oosterhout, M., et al. Clinical Efficacy of Infliximab Plus Methotrexate in DMARD Naive and DMARD Refractory Rheumatoid Arthritis Is Associated With Decreased Synovial Expression of TNFα and IL18 but Not CXCL12. 2005.